文献速递慢性肾脏病

肾功能斜率与CKD患者长期死亡及心血管事件的关联

Slope of Kidney Function and Its Association with Longitudinal Mortality and Cardiovascular Disease among Individuals with CKD.
PubMed 文献 · J Am Soc Nephrol · 2020-10-06

该研究纳入2738例中重度CKD患者,采用线性混合效应模型估算eGFR斜率,并用Cox模型分析斜率与死亡及心血管事件风险的关系。结果显示,eGFR下降速度超过平均水平与死亡和心血管事件风险增加相关,而eGFR上升或下降慢于平均水平未增加风险。

要点

  • eGFR快速下降与CKD患者死亡和心血管事件风险增加独立相关。
  • eGFR上升或下降缓慢未显示与死亡或心血管事件风险增加相关。
  • eGFR斜率可能有助于CKD患者的临床风险评估。

核心结论

  • 在中重度CKD患者中,eGFR下降速度陡于平均水平与死亡和心血管事件风险逐渐增加相关。
  • eGFR上升或下降速度慢于平均水平未与死亡或心血管事件风险增加相关。

研究设计与样本

  • 研究纳入2738例中重度CKD患者,来自多中心慢性肾功能不全队列研究。
  • 采用线性混合效应模型估算eGFR斜率,最多基于四次年度eGFR评估。
  • 采用Cox比例风险模型分析斜率与死亡及心血管事件风险的关联。

主要发现

  • eGFR斜率呈钟形分布,均值(标准差)为-1.5(-2)ml/min per 1.73 m2 per year。
  • eGFR下降速度较平均值陡1个标准差时,死亡风险比为1.23(95%CI 1.09至1.39)。
  • eGFR下降速度较平均值陡1个标准差时,心血管事件风险比为1.19(95%CI 1.03至1.38)。

临床怎么用

  • 临床评估CKD成人患者时,可考虑使用eGFR斜率辅助风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Slopes of eGFR have been associated with increased risks of death and cardiovascular events in a U-shaped fashion. Poor outcomes in individuals with rising eGFR are potentially attributable to sarcopenia, hemodilution, and other indicators of clinical deterioration. METHODS: To investigate the association between eGFR slopes and risks of death or cardiovascular events, accounting for multiple confounders, we studied 2738 individuals with moderate to severe CKD participating in the multicenter Chronic Renal Insufficiency Cohort (CRIC) Study. We used linear, mixed-effects models to estimate slopes with up to four annual eGFR assessments, and Cox proportional hazards models to investigate the association between slopes and the risks of death and cardiovascular events. RESULTS: Slopes of eGFR had a bell-shaped distribution (mean [SD], -1.5 [-2] ml/min per 1.73 m2 per year). Declines of eGFR that were steeper than the average decline associated with progressively increasing risks of death (hazard ratio [HR], 1.23; 95% confidence interval [95% CI], 1.09 to 1.39; for a slope 1 SD below the average) and cardiovascular events (HR, 1.19; 95% CI, 1.03 to 1.38). Rises of eGFR or declines lower than the average decline were not associated with the risk of death or cardiovascular events. CONCLUSIONS: In a cohort of individuals with moderate to severe CKD, we observed steep declines of eGFR were associated with progressively increasing risks of death and cardiovascular events; however, we found no increased risks associated with eGFR improvement. These findings support the potential value of eGFR slopes in clinical assessment of adults with CKD.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Orlandi PF, Xie D, Yang W, et al. Slope of Kidney Function and Its Association with Longitudinal Mortality and Cardiovascular Disease among Individuals with CKD. J Am Soc Nephrol. 2020. PMID: 33023926. doi:10.1681/ASN.2020040476

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。